Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5208]

Osimertinib plus chemo improves survival across high-risk subgroups in EGFR...

Dr Pasi Janne - Dana-Farber Cancer Institute, Boston, USA

Osimertinib plus chemo improves survival across high-risk subgroups in EGFR-mutated aNSCLC ( Dr Pasi Janne - Dana-Farber Cancer Institute, Boston, USA )

Low-dose pembrolizumab plus neoadjuvant chemo option for TNBC in resource...

Dr Atul Batra - All India Institute Of Medical Sciences Delhi, New Delhi, India

Low-dose pembrolizumab plus neoadjuvant chemo option for TNBC in resource-constrained settings ( Dr Atul Batra - All India Institute Of Medical Sciences Delhi, New Delhi, India )

Domvanalimab, zimberelimab and FOLFOX shows durable survival in advanced HER2...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Domvanalimab, zimberelimab and FOLFOX shows durable survival in advanced HER2-negative GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Abemaciclib combined with endocrine therapy improves OS in high-risk HR+, HER2−...

Prof Stephen Johnston - The Royal Marsden, London, UK

Abemaciclib combined with endocrine therapy improves OS in high-risk HR+, HER2− early breast cancer ( Prof Stephen Johnston - The Royal Marsden, London, UK )

Avelumab maintenance after reduced chemotherapy cycles improves QoL without...

Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain

Avelumab maintenance after reduced chemotherapy cycles improves QoL without sacrificing survival in aUC ( Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain )

Durvalumab combined with FLOT improves survival in resectable gastric and GEJ...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Proton vs photon radiotherapy shows similar patient-reported quality of life in...

Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA

Proton vs photon radiotherapy shows similar patient-reported quality of life in breast cancer patients ( Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA )

NSCLC brain metastases: TTFields after SRS delays intracranial progression...

Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois...

NSCLC brain metastases: TTFields after SRS delays intracranial progression without affecting QoL ( Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois, USA )

Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer

Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland...

Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer ( Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland, USA )

ctDNA testing improves detection of treatable metastases compared to standard...

Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA

ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer ( Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA )

Non-clear cell renal cell carcinoma: Management of papillary RCC

Prof Camillo Porta and Prof Laurence Albiges

Non-clear cell renal cell carcinoma: Management of papillary RCC ( Prof Camillo Porta and Prof Laurence Albiges )

Bladder cancer updates from the first half of 2025

Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone...

Bladder cancer updates from the first half of 2025 ( Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Benjamin Pradere )

More from ecancer